Raidenta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 42,429 | 56,764 | 77,106 | 170,153 | 229,090 | 228,881 | 210,712 | 244,994 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 3,516 | 5,114 | 19,941 | 54,873 | 35,272 | 41,281 | 4,727 | 51,166 |
| Equity | 25,188 | 30,302 | 50,243 | 100,410 | 123,918 | 139,316 | 122,867 | 134,621 |
| Liabilities | 21,582 | 18,832 | 29,355 | 20,997 | 10,889 | 10,628 | 40,520 | 81,586 |
| Non-current assets | 29,399 | 23,232 | 39,390 | 61,048 | 72,170 | 69,782 | 83,952 | 129,287 |
| Current assets | 17,313 | 25,269 | 39,673 | 59,893 | 68,414 | 79,303 | 78,728 | 85,656 |
| Total assets | 46,712 | 48,501 | 79,063 | 120,941 | 140,584 | 149,085 | 162,680 | 214,943 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 15,522 | 13,574 | 16,820 |
| Social insurance contributions | - | - | - | - | - | 15,186 | 17,665 | 7,190 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +28.9% | +33.8% | +35.8% | +120.7% | +34.6% | -0.1% | -7.9% | +16.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.5% | 10.5% | 25.2% | 45.4% | 25.1% | 27.7% | 2.9% | 23.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 14.0% | 16.9% | 39.7% | 54.6% | 28.5% | 29.6% | 3.8% | 38.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.3% | 9.0% | 25.9% | 32.2% | 15.4% | 18.0% | 2.2% | 20.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.3 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,184 | 18,921 | 24,349 | 60,055 | 57,273 | 46,552 | 42,142 | 58,798 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Raidenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-03-16 | 2023-03-22 | 5.37 |
Raidenta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-02 | 2026-03-02 | 47.29 |
| 2026-02-21 | 2026-03-01 | 47.18 |
| 2025-02-02 | 2025-02-09 | 2.08 |
| 2025-02-01 | 2025-02-01 | 1.52 |
| 2025-01-19 | 2025-01-31 | 139.46 |
| 2025-01-14 | 2025-01-18 | 138.83 |
| 2025-01-08 | 2025-01-13 | 114.98 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Raidenta, UAB (company code 302721137) is a Private Limited Liability Company engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated EUR 245.0K in revenue, up 16.3% year on year and 7.0% over two years. Net profit increased to EUR 51.2K, compared with EUR 4.7K in 2024 and EUR 41.3K in 2023, while the profit margin improved to 20.9% after 2.2% in 2024 and 18.0% in 2023. The 2025 result shows a clear recovery in profitability alongside higher sales.
The balance sheet also strengthened in 2025, with total assets rising to EUR 214.9K from EUR 162.7K in 2024. Equity amounted to EUR 134.6K and liabilities to EUR 81.6K, giving an equity ratio of 62.6% and debt-to-equity of 0.61. Long-term assets increased to EUR 129.3K, while short-term assets reached EUR 85.7K. Efficiency remained solid, with asset turnover at 1.14x, ROE at 38.0%, ROA at 23.8%, revenue per employee at EUR 61.2K and profit per employee at EUR 12.8K.
The balance sheet also strengthened in 2025, with total assets rising to EUR 214.9K from EUR 162.7K in 2024. Equity amounted to EUR 134.6K and liabilities to EUR 81.6K, giving an equity ratio of 62.6% and debt-to-equity of 0.61. Long-term assets increased to EUR 129.3K, while short-term assets reached EUR 85.7K. Efficiency remained solid, with asset turnover at 1.14x, ROE at 38.0%, ROA at 23.8%, revenue per employee at EUR 61.2K and profit per employee at EUR 12.8K.